Allergy and immunology Foundation of Australasia (AIFA)
AIFA was established in 2013 by ASCIA to fund medical research into allergy and other immune diseases.
The research studies listed below are currently being undertaken in Australia and New Zealand and involve ASCIA members.
AADRY - Australian Autoinflammatory Diseases RegistrY Study
ANZADA - Australia and New Zealand Antibody Deficiency Allele Study
ANZADA is a national collaborative research project supported by the NHMRC that aims to identify the cellular and genetic causes of antibody deficiency diseases, including CVID, IgA deficiency, and specific antibody deficiency. The study is recruiting patients of any age with any of these disorders.
APAP - Australian Pollen Allergen Partnership
This project aims to deliver translatable results to improve the management of pollen exposure and the health of individuals with allergic rhinitis and asthma.
This project has recently been awarded an AIFA grant.
For more information go to www.australianpollen.com.au/
APOSLE - Australia point mutation in SLE Study
APOSLE is a national collaborative research project supported by the NHMRC that aims to identify the cellular and genetic causes of systemic lupus erythematosus.
BEAT - Beating Egg Allergy Trial
The BEAT trial is investigating the effect of early introduction of egg into the diet of infants at high risk for atopy and subsequent egg allergy.
Centre for Food & Allergy Research (CFAR)
A collaborative group of Australian allergy researchers are involved in an NHMRC funded national Centre fo Food & Allergy Research (CFAR), which aims to curb the food allergy epidemic.
or go to www.foodallergyresearch.org.au
This study aims to find the cause of common variable immunodeficiency (CVID) and is being conducted by researchers at the Walter and Eliza Hall Institute and the Royal Melbourne Hospital. If you are aged between 18 and 80 and have been diagnosed with CVID or XLA, you are eligible to participate.
For more information go to www.wehi.edu.au/PIDdonor
DOMInO 6 (DHA to Optimise Maternal and Infant Outcomes 6 year follow up study).
This is a 6 year follow up of children born to mothers in the DOMInO study, a randomised controlled trial to investigate the effect of maternal supplementation with omega-3 long chain poly-unsaturated fatty acids (LCPUFA) in pregnancy on clinical outcomes of allergic disease in the child.
Immune milk proteins for the treatment of eczema
Immune proteins in milk have shown promise in pre-clinical studies to improve the symptoms of eczema. The aim of this study being run at the St George Dermatology and Skin Cancer Centre in Sydney is to determine if enriched milk proteins taken as a supplement for 8 weeks reduce the severity of eczema symptoms. The study is now recruiting participants with eczema.
Predicting shellfish sensitisation among dust mite allergic children
The Chief Investigator for this project is Dr Sandip Kamath, a postdoctoral researcher based at James Cook University.
This project was recently awarded an AIFA Early Career Researcher grant.
For more information go to http://research.jcu.edu.au/bmdt/grants-shellfish-allergy-in-children-dr-sandip-kamath-wins-aifa-grant
STEP - Starting Time for Egg Protein Study
This collaborative study is being conducted in Adelaide and Perth hospitals.
TiARA - Tick induced Allergies Research and Awareness
This research and educational fund has been established at Royal North Shore Hospital, Sydney, NSW.
or write to Clinical A/Professor Sheryl van Nunen, Department of Clinical Immunology and Allergy, Royal North Shore Hospital St Leonards NSW 2065
Content updated July 2016